Oct 28, 2024 | Federal Trade Commission (FTC), Pharmacy, Pharmacy Benefits Manager (PBM), Rebates, Spread Pricing
KFF Health News reports on the disparity between pharmacy benefit manager (PBM) payments to large pharmacy chains compared to small drugstores: “[An American Pharmacy Cooperative] analysis early this year showed chains were paid well beyond the family business...
Sep 27, 2024 | Drug advertising, Drug costs, Pharmacy, Rebates, Study
KFF Health News warns consumers not to take TV drug ads at face value: “A 2023 study found that, among top-selling drugs, those with the lowest levels of added benefit tended to spend more on advertising to patients than doctors. ‘I worry that...
Oct 3, 2023 | MedBen Rx, Pharmacy Benefits Manager (PBM), Rebates, White paper
In their continuing quest for bigger profits, major pharmacy benefit managers (PBMs) have adapted a new tactic: clever wordplay. What was once known as a “rebate” – a partial refund of the drug payment back to the plan – now goes by a variety of other...
Jul 12, 2022 | MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rebates
MedBen Rx has prepared a whitepaper detailing the games pharmacy benefit managers (PBMs) play with administrative and rebate credits. PBMs focus on fixed cost savings to make you think you’re saving on prescription costs… but a closer look reveals that you’re going to...
Oct 16, 2020 | Claims Management, Cost Savings, Direct-to-Employer Contracting, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rebates, Reference-Based Pricing, Rx Costs, Savings, Spread Pricing
A National Alliance of Healthcare Purchaser Coalitions survey asked employers what they thought were the greatest threats to coverage affordability. Their responses… and how MedBen counters these concerns with proven saving solutions: Drug prices are a threat to...
Sep 18, 2020 | Cost Savings, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rebates, Rx Costs, Specialty Drugs, Transparency
Employers could save billion of dollars every year by avoiding “wasteful drugs,” according to BenefitsPro. Guidelines from Pacific Business Group on Health and and researchers from Johns Hopkins University identified 49 high-price medications with less...
